These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1536794)

  • 1. Malignant melanoma, Breslow thickness and public education campaigns.
    Bucchi L; Serafini M; Crisanti E; Stanganelli I; Rafanelli S
    Br J Dermatol; 1992 Feb; 126(2):205-6. PubMed ID: 1536794
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinicopathological analysis of 1571 cutaneous malignant melanomas in Valencia, Spain: factors related to tumour thickness.
    Nagore E; Oliver V; Botella-Estrada R; Moreno-Picot S; Guillén C; Fortea JM
    Acta Derm Venereol; 2006; 86(1):50-6. PubMed ID: 16585990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thin primary cutaneous melanomas: associated detection patterns, lesion characteristics, and patient characteristics.
    Schwartz JL; Wang TS; Hamilton TA; Lowe L; Sondak VK; Johnson TM
    Cancer; 2002 Oct; 95(7):1562-8. PubMed ID: 12237926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node biopsy in elderly irish patients with malignant melanoma.
    Moran DE; Smith MJ; O'Sullivan MJ; Bannon H; Crotty TB; Collins CD; Skehan SJ; O'Higgins N; McDermott EW; Evoy D; Hill AD
    Ir Med J; 2007 Apr; 100(4):422-4. PubMed ID: 17566474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with a high tumour thickness in patients with melanoma.
    Baumert J; Plewig G; Volkenandt M; Schmid-Wendtner MH
    Br J Dermatol; 2007 May; 156(5):938-44. PubMed ID: 17381454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.
    Paek SC; Griffith KA; Johnson TM; Sondak VK; Wong SL; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
    Cancer; 2007 Jan; 109(1):100-8. PubMed ID: 17146784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiology and prognostic factors in cutaneous malignant melanoma].
    Milo Y; Tamir G; Robinpour M; Sulkes J; Rotem A; Schachter J; Hauben DJ
    Harefuah; 1995 Jun; 128(12):745-51, 824. PubMed ID: 7557679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stage I malignant melanoma of the skin. Prognostic value of thickness and level (author's transl)].
    Palangié A; Lassau F; Moreau T; Noury-Duperrat G; Cottenot F
    Nouv Presse Med; 1981 Jun; 10(28):2337-41. PubMed ID: 7267338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of sentinel node biopsy in 327 prospective melanoma patients from a single institution.
    Roulin D; Matter M; Bady P; Liénard D; Gugerli O; Boubaker A; Bron L; Lejeune FJ
    Eur J Surg Oncol; 2008 Jun; 34(6):673-9. PubMed ID: 17825518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The importance of prognostic factors in malignant melanoma of the skin].
    Bischoff I; Wozniak KD
    Arch Geschwulstforsch; 1989; 59(6):463-7. PubMed ID: 2596960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
    Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
    Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time trends in tumour thickness vary in subgroups: analysis of 6475 patients by age, tumour site and melanoma subtype.
    Baumert J; Schmidt M; Giehl KA; Volkenandt M; Plewig G; Wendtner C; Schmid-Wendtner MH
    Melanoma Res; 2009 Feb; 19(1):24-30. PubMed ID: 19430403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malignant melanoma: prognostic evaluation using correlation coefficients].
    Kühnl-Petzoldt C; Berger H; Wiebelt H
    Hautarzt; 1983 Aug; 34(8):398-402. PubMed ID: 6618884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relation of the clinical course of malignant melanoma of the skin and its population features, site, staging and histopathologic characteristics].
    Chmielowska E
    Patol Pol; 1988; 39(2):83-93. PubMed ID: 3251184
    [No Abstract]   [Full Text] [Related]  

  • 15. [After diagnosing melanoma in a patient: evaluation of risks of second melanoma and melanoma in the family].
    Cesarini JP; Beltzer-Garelly E; Binet O
    Ann Dermatol Venereol; 1995; 122(5):305-9. PubMed ID: 8572471
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inpatient and outpatient follow-up of grade I malignant melanoma].
    Cordel N; Safa G; Balguerie X; De Preville P; Modeste A; Courville P; Boivin C; Pellerin A; Ziade J; Thiberville G; Laaengh-Michel N; Neveu C; Young P; Lauret P; Joly P
    Ann Dermatol Venereol; 2000; 127(6-7):579-83. PubMed ID: 10930854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma.
    Scala S; Ottaiano A; Ascierto PA; Cavalli M; Simeone E; Giuliano P; Napolitano M; Franco R; Botti G; Castello G
    Clin Cancer Res; 2005 Mar; 11(5):1835-41. PubMed ID: 15756007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society.
    Leiter U; Buettner PG; Eigentler TK; Garbe C
    J Clin Oncol; 2004 Sep; 22(18):3660-7. PubMed ID: 15302905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indications for prophylactic lymphadenectomy in skin melanoma of the lower limbs].
    Vagner RI; Anisimov VV
    Vopr Onkol; 1986; 32(12):13-8. PubMed ID: 3798833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma in middle-aged and older men: a multi-institutional survey study of factors related to tumor thickness.
    Swetter SM; Johnson TM; Miller DR; Layton CJ; Brooks KR; Geller AC
    Arch Dermatol; 2009 Apr; 145(4):397-404. PubMed ID: 19380661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.